ENvue Medical (FEED) Cash from Financing Activities (2014 - 2026)

ENvue Medical (FEED) has 12 years of Cash from Financing Activities data on file, last reported at $2.3 million in Q1 2026.

• On a quarterly basis, Cash from Financing Activities rose 122.86% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $14.1 million, a 1275.95% increase from a year earlier, with the FY2025 full-year figure at $12.8 million, up 1278500.0% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $2.3 million, up from -$34000.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for FEED reached as high as $6.8 million in Q2 2025 and fell as low as -$34000.0 in Q4 2025.
• Historically, Cash from Financing Activities has averaged $2.4 million across 4 years, with a median of $1.7 million in 2025.
• Across the five-year window, Cash from Financing Activities tumbled 100.64% in 2024 and soared 18322.22% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at $4.2 million in 2023, then plunged by 100.64% to -$27000.0 in 2024, then retreated by 25.93% to -$34000.0 in 2025, then surged by 6982.35% to $2.3 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $2.3 million in Q1 2026, -$34000.0 in Q4 2025, and $4.9 million in Q3 2025.